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Background/Significance
▪ Purpose: To compare the rates of phlebitis and infection rates of

peripherally inserted intravenous catheters that are changed when
clinically indicated rather than routinely (every 72 hours)

▪ When talking to nurses:
• Many times after a thorough IV site assessment a pt’s IV will be patent
with blood return after 72 hours, as per hospital policy the IV will be
removed and the pt will have a new IV placed only to no longer need
the IV in another 24 hours.
• Pt’s that are difficult sticks may require up to 4 attempts before
obtaining a new IV. Extending the usage of a usable IV could save
patients the discomfort of multiple IV placement attempts.

PICO QUESTION
▪ In ICU patients, how do phlebitis and infection
rates compare when peripherally inserted IV’s
are changed routinely versus when clinically
indicated?

P: ICU patients with peripheral IVs
I: Clinically indicated peripheral IV changes
C: Routine peripheral IV changes
O: Rates of infection and phlebitis

TRIGGER?
▪ Problem Focused Trigger
• Reported frustration of nurses with frequent
IV changes
– Insufficient evidence to support routinely changing
IV’s every 72 hours
– Increased cost
– Decreased patient satisfaction

EVIDENCE
▪

▪

Search Engines:
• EBSCOhost Research database, CINAHL, Medline, Cochrane Database
of Systematic Reviews

Key Words:
• Clinically indicated replacement vs. Catheter removal; Peripherally
inserted catheter; Catheter removal and peripherally inserted central
catheter; Catheter related infections or catheter related blood stream
infections or catheter related complications or catheter related
thrombosis and catheter related infections/PC and Treatment
outcomes or nursing outcomes

▪

See attached evidence table and following slides for
more information

EVIDENCE
▪

Decreased or equal rates of phlebitis
• Phlebitis occurred in 7% of patients with both clinically replaced IVs and
routinely replaced IVs
• Peripheral venous thrombophlebitis developed in 11/26 patients in the
control group and 1/21 patients in the study group (P = 0.003).
• Independent of study group, the rate of phlebitis and/or occlusion at 96
hours was 23.4% (74 of 316 IVs), which was identical to the rate of
phlebitis and/or occlusion associated with the 111 IVs used beyond 96
hours.
• No significant difference in phlebitis or infiltration rates in the intervention
group(38%) compared with the control group(33%). When the analysis
was based on failure per 1000 device days (number of failures divided by
number of days catheterised, divided by 1000), no difference could be
detected between the groups. The rate of phlebitis in both groups was low
(4% in intervention group, 3% in control group).

▪

Decreased or equal rates on infection
• No significant difference between CRBSI rate.
• No IVD related blood stream infections in either groups

EVIDENCE
▪

Decreased costs
▪ More IVDs placed per patient in the control or the routinely changed PIV
group, with higher hospital costs per patient
▪ Cost of cannula replacements in the control group AUD$3,837.56
and in the intervention group was AUD$3,183.62
▪ Infusion related costs were higher in the control group (mean
$A41.02) than intervention group ($A36.40).

▪

Increased patient satisfaction
▪ Decreased replacements (decreased “sticks) of PIV

▪

Overall decreased or equal complication rates
▪ IVD complication rates 68 per 1,000 IVD days for clinically indicated
replacement and 66 per 1,000 IVD days for routine replacement

▪

A thorough assessment and maintenance of PIVs can save a nurse more time in
the long run!

Current Practice at LVHN
▪ "Peripheral short catheters sites should be
changed every 72 hours in the adult population.
Catheters placed in pre-hospital or institutions
other than LVH Facilities are to be replaced
within 24 hours of admission unless
contraindicated. (Infusion Nursing Standard
Practice Jan/Feb 2006. 29. pp. S51)."

IMPLEMENTATION (outline)
1. Process Indicators and Outcomes
2. Baseline Data
3. Design (EBP) Guideline(s)/Process
4. Implemented EBP on Pilot Units
5. Evaluation (Post data) of Process & Outcomes
6. Modifications to the Practice Guideline
7. Network Implementation

IMPLEMENTATION
1.

Indicators and Outcomes

Indicators:
▪
Adverse Affects of Routine vs. Clinically Indicated IV Changes
▪
Patient Satisfaction of PIV Insertion and Replacements
Outcome Measurements:
▪
Patient Satisfaction
▪
Time Saved
▪
Cost Efficiency

IMPLEMENTATION (cont.)
2. Baseline Data Obtained In TNICU
▪ Approximately 90% of patients have a PIV at some point during stay on unit.
▪ Approximately 65% keep PIV throughout stay in hospital
▪ Patient X hospitalized 90 days
• Total IV’s 39 ( 3 IV’s pulled prior to 72hrs)
• Estimated PIV’s needed for 72 hour changes =30
• Estimated PIV’s needed for 95 hour changes =23
• Average estimated cost per PIV insertion placed on initial attempt $41.00.
• Estimated saving if PIV use extended to 96 hours ( 7 less PIV’s) $287.00.

▪

According to U.S. News and World Report LVH-CC had 44,853 admissions
in 2014. With an average estimated cost of $41.00 per PIV insertion, if
obtained on the initial attempt. If PIV usage was extended to 96 hours and
each admission had one less PIV’s and estimated $1,838,973 would be
saved in one year.

EBP Guidelines/Process Change
Assessment of Peripheral
I.V. at least every 4 hours

No Infiltration

No Extravasation

Continue to reassess site every 4
hours up to 96 hours

No Infection

IMPLEMENTATION (cont.)
4. Implemented EBP on Pilot Units
• Project approval denied by Infectious Disease therefore unable to
implement on TNICU

5. Evaluation (Post data) of Process & Outcomes
• Not applicable
• Theoretically, based on research data no change or increase in
infection and phlebitis rates when PIV’s are changed routinely as
current policy dictates versus when clinically indicated per research

6. Modifications to the Practice Guideline
• None at this time

7. Network Implementation
• Continue to research data on PIV maintenance and suggested
replacement times to present to Infectious Disease

RESULTS
• Theoretically, based on research data no
change or increase in infection and phlebitis
rates when PIV’s are changed routinely as
current policy dictates versus when clinically
indicated per research

Implications for LVHN
▪ This project has the potential to increase
patient satisfaction, decrease hospital
costs, and continue to maintain safety for
patients in terms of infection and phlebitis
rates related to PIV’s

Lessons Learned
▪Ample research and data is needed in order to obtain
approval for changes in hospital policy

▪It is difficult to change a policy that was

implemented due to past safety issues
• Previously, there were rises in infection and
phlebitis rates related to PIV’s that were not
changed routinely

▪In order to implement change within the hospital,
teamwork and cooperation are needed among
multiple interdisciplinary groups
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Make It Happen
Questions or comments may be directed to:
Juliet Hahn
Zinah Heisel
Devin Pond
TNICU – 610-402-8930

